| Description |
1 online resource (4 volumes) : color illustrations |
| Series |
Gale eBooks
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
v. 1. Abarelix. Acalabrutinib. Accelerated partial breast irradiation. Acoustic neuroma. Acute erythroblastic leukemia. Acute lymphocytic leukemia. Acute myeloid leukemia. Adenocarcinoma. Adenoma. Adjuvant chemotherapy. Ado-trastuzumab emtansine. Adrenal fatigue. Adrenal tumors. Adrenocortical carcinoma. Adult cancer pain. Advance directives. Afatinib. AIDS-related cancers. Alcohol consumption and cancer. Aldesleukin. Alemtuzumab. Allopurinol. Alopecia. Alpelisib. Altretamine. Amantadine. Amenorrhea. American Joint Committee on Cancer. Amifostine. Aminoglutethimide. Amitriptyline. Amputation. Amsacrine. Anagrelide. Anal carcinoma. Anemia. Angiogenesis. Angiogenesis inhibitors. Angiography. Anorexia. Anoscopy. Antiandrogens. Antibiotics. Anticancer drugs. Antidiarrheal agents. Antiemetics. Antiestrogens. Antifungal therapy. Antimicrobials. Antineoplastic agents. Antioxidants. Antiviral therapy. Apalutamide. Aromatase inhibitors. Arsenic trioxide. Ascites. Asparaginase. Astrocytoma. Atezolizumab. Avelumab. Axicabtagene ciloleucel. Axillary dissection. Azacitidine. Azathioprine. Bacillus Calmette-Guerin. Barium enema. Barrett's esophagus. Basal cell carcinoma. BCR-ABL inhibitors. Bendamustine hydrochloride. Benzene. Benzodiazepines. Bevacizumab. Bexarotene. Bile duct cancer. Biological response modifiers. Biopsy. Bispecific antibodies. Bisphosphonates. Bladder cancer. Bleomycin. Body image/self-image. Bone marrow aspiration and biopsy. Bone marrow transplantation. Bone pain. Bone survey. Bortezomib. Bowen disease. Brain and central nervous system tumors. BRCA1 and 2. Breast cancer. Breast reconstruction. Breast self-exam. Breast ultrasound. Bronchoalveolar lung cancer. Bronchoscopy. Burkitt lymphoma. Buserelin. Busulfan. Cabozantinib. Calcitonin. Cancer. Cancer biology. Cancer cluster. Cancer diet. Cancer genetics. Cancer insurance. Cancer of unknown primary. Cancer predisposition. Cancer prevention. Cancer research. Cancer screening guidelines for men. Cancer screening guidelines for women. Cancer stem cells. Cancer survivorship issues. Cancer therapy, palliative. Cancer vaccines. Cancer-fighting foods. Capecitabine. Capsaicin. Carbamazepine. Carboplatin. Carcinogenesis. Carcinogens. Carcinoid tumors, gastrointestinal. Carcinoid tumors, lung. Carcinomatous meningitis. Cardiomyopathy. Carfilzomib. Carmustine. Cartilage supplements. Castleman disease. Center for Medicare and Medicaid services. Central nervous system carcinoma. Central nervous system lymphoma. Cervical cancer. Cetuximab. Checkpoint inhibitors. Chemoembolization. Chemoprevention. Chemotherapy. Childhood cancers. Chimeric antigen receptor T-cell therapy. Chlorambucil. Chondrosarcoma. Chordoma. Choroid plexus tumors. Chromosome rearrangements. Chronic lymphocytic leukemia. Chronic myelocytic leukemia. Cigarettes. Cisplatin. Cladribine. Clinical trial endpoints. Clinical trials. Coenzyme Q10. Colectomy. Colon cancer. Colonoscopy. Colorectal surgery. Colostomy. Complementary cancer therapies. Computed tomography. Cone biopsy. Corticosteroids. Covid-19 and cancer. |
|
v. 2. Craniopharyngioma. Craniosynostosis. Craniotomy. Cryotherapy. CT-guided biopsy. Cushing syndrome. Cutaneous T-cell lymphoma. Cyclooxygenase 2 inhibitors. Cyclophosphamide. Cyclosporine. Cystectomy. Cystosarcoma phyllodes. Cystoscopy. Cytarabine. Cytogenetic analysis. Cytokine release syndrome. Cytology. Cytomegalovirus. Dabrafenib. Dacarbazine. Daclizumab. Dactinomycin. Danazol. Daratumumab. Darolutamide. Dasatinib. Daunorubicin. Debulking surgery. Degarelix. Demeclocycline. Denileukin diftitox. Denosumab. Depression. Dermatofibrosarcoma protuberans. Dexamethasone. Dexrazoxane. Diarrhea. Diazepam. Dietary factors and cancer risk. Diethylstilbestrol diphosphate. Diffuse large B-cell lymphoma. Digital rectal examination. Dilatation and curettage. Diphenhydramine. Disseminated intravascular coagulation. DNA flow cytometry. DNA methyltransferase inhibitors. Docetaxel. Doxorubicin. Drug resistance. Ductogram. Dutasteride. Endocrine system tumors. Endometrial cancer. Endorectal ultrasound. Endoscopic retrograde cholangiopancreatography. Enfortumab vedotin-ejfv. Enteritis. Entrectinib. Environmental factors in cancer development. Enzalutamide. Ependymoma. Epidermal growth factor receptor antagonists. Epigenetics. Epirubicin. Epstein-Barr virus. Erdafitinib. Erlotinib. Erythropoiesis-stimulating agents. Esophageal cancer. Esophageal resection. Esophagogastrectomy. Essiac. Estramustine. Etoposide. Everolimus. Ewing sarcoma. Exenteration. Extracranial germ cell tumors. Extragonadal germ cell tumors. Familial cancer syndromes. Family and caregiver issues. Fam-trastuzumab deruxtecanxki. Fanconi anemia. Fatigue. Fecal occult blood test. Fedratinib. Fertility issues. Fever. Fibrocystic condition of the breast. Fibrosarcoma. Filgrastim. Flow cytometry. Floxuridine. Fludarabine. Fluorouracil. Fluoxymesterone. Folic acid. Follicular lymphoma. Gabapentin. Gallbladder cancer. Gallium nitrate. Gallium scan. Gastrectomy. Gastroduodenostomy. Gastrointestinal cancers. Gastrointestinal complications. Gefitinib. Gemcitabine. Gemtuzumab. Gene therapy. Genetic testing. Germ cell tumors. Gestational trophoblastic tumors. Giant cell tumors. Gilteritinib. Global cancer incidence and mortality. Glossectomy. Glutamine. Goserelin acetate. Graft-versus-host disease. Gynecologic cancers. Hairy cell leukemia. Hand-foot syndrome. Head and neck cancers. Health insurance. Hemolytic anemia. Hemoptysis. Heparin. Hepatic arterial infusion. Herbs. Herpes simplex. Herpes zoster. Histamine 2 antagonists. Hodgkin lymphoma. Home health services. Horner syndrome. Hospice care. Human growth factors. Human papillomavirus. Hydroxyurea. Hypercalcemia. Hypercoagulation disorders. Hyperthermia. Hypocalcemia. Ibritumomab. Ibrutinib. Idarubicin. Ifosfamide. Imaging studies. Imatinib mesylate. Immune effector cell-associated neurotoxicity syndrome (ICANS). Immune globulin. Immune response. Immunoelectrophoresis. Immunohistochemistry. Immunotherapy. Incontinence, cancer-related. Infection and sepsis. Intensity-modulated radiation therapy. Interferons. Interleukin 2. Intrathecal chemotherapy. Intravenous urography. Investigational drugs. Irinotecan. Itching. Ivosidenib. Ixazomib. Kaposi sarcoma. Ki67. Kidney cancer. Lambert-Eaton myasthenic syndrome. Laparoscopy. Lapatinib. Laryngeal cancer. Laryngeal nerve palsy. Laryngectomy. Laryngoscopy. Late effects of cancer treatment. Laxatives. Leiomyosarcoma. Lenalidomide. Leucovorin. Leukemias, acute. Leukemias, chronic. Leukoencephalopathy. Leukotriene inhibitors. Leuprolide acetate. Levamisole. Li-Fraumeni syndrome. Limb salvage. Lip cancer. Liver biopsy. Liver cancer. Lobectomy. Lomustine. Lorazepam. Low molecular weight heparins. |
|
v. 3. Lumbar puncture. Lumpectomy. Lung biopsy. Lung cancer, non-small cell. Lung cancer, small cell. Lymph node biopsy. Lymph node dissection. Lymphadenopathy. Lymphangiography. Lymphocyte immune globulin. Lymphoma. Lymphopenia. Magnetic resonance imaging. Male breast cancer. Malignant fibrous histiocytoma. MALT lymphoma. Mammography. Mantle cell lymphoma. Marginal zone lymphoma. Mastectomy. Matrix metalloproteinase inhibitors. Mechlorethamine. Meclizine. Mediastinal tumors. Mediastinoscopy. Medical marijuana/Cannaboid drugs. Medroxyprogesterone acetate. Medulloblastoma. Megestrol acetate. Melanoma. Melphalan. Memory change. Meningioma. Meperidine. Mercaptopurine. Merkel cell carcinoma. Mesna. Mesothelioma. Metastasis. Methotrexate. Methylphenidate. Metoclopramide. Micronutrients and cancer prevention. Minimal residual disease. Mistletoe. Mitomycin-C. Mitotane. Mitoxantrone. Modified radical mastectomy. Mohs surgery. Monoclonal antibodies. Mucositis. Multiple endocrine neoplasia syndromes. Multiple myeloma. Myasthenia gravis. Mycophenolate mofetil. Mycosis fungoides. Myelodysplastic syndromes. Myelofibrosis. Myeloproliferative diseases. Myelosuppression. Nasal cancer. Nasopharyngeal cancer. National Cancer Institute. National Comprehensive Cancer Network. Nausea and vomiting. Nephrectomy. Nephrostomy. Neuroblastoma. Neuroendocrine tumors. Neuropathy. Neurotoxicity. Neutropenia. Next-generation sequencing. Night sweats. Nilotinib. Niraparib. Nivolumab. Non-Hodgkin lymphoma. Nonsteroidal anti-inflammatory drugs. Nuclear medicine scans. Nutritional support. Obesity and cancer risk. Obinutuzumab. Occupational exposures and cancer. Ofatumumab. Olaparib. Oligodendroglioma. Omega-3 fatty acids. Ommaya reservoir. Oncologic emergencies. Oophorectomy. Opioids. Oprelvekin. Oral cancers. Orchiectomy. Oropharyngeal cancer. Osteosarcoma. Ovarian cancer. Ovarian epithelial cancer. Paget disease of the breast. Pain management. Pancreatectomy. Pancreatic cancer. Pancreatic cancer, endocrine. Pancreatic cancer, exocrine. Panitumumab. Panobinostat. Pap test. Paracentesis. Paranasal sinus cancer. Paraneoplastic syndromes. Parathyroid cancer. Patient reported outcomes. PC-SPES. Pediatric cancer. Pegaspargase. Pembrolizumab. Pemetrexed. Penile cancer. Pentostatin. Percutaneous transhepatic cholangiography. Pericardial effusion. Pericardiocentesis. Peritoneovenous shunt. Pesticides. Peutz-Jeghers syndrome. Pharyngectomy. Phenytoin. Pheochromocytoma. Pheresis. Photodynamic therapy. Physical therapy. Pilocarpine. Pineoblastoma. Pituitary tumors. Plerixafor. Pleural biopsy. Pleural effusion. Pleurodesis. Ploidy analysis. Pneumonectomy. Pneumonia. Polatuzumab vedotin-piiq. Polyomavirus hominis type 1 (BK virus) infection. Pomalidomide. Porfimer sodium. Positron emission tomography. Pregnancy and cancer. Procarbazine. Prostate cancer. Prostatectomy. Proteasome inhibitors. Protein electrophoresis. Proteomics. Psycho-oncology. Quadrantectomy. Radiation dermatitis. Radiation therapy. Radical neck dissection. Radiofrequency ablation. Radiofrequency energy and cancer risk. Radiopharmaceuticals. Raloxifene. Ramucirumab. Receptor analysis. Reconstructive surgery. Rectal cancer. Rectal resection. Regorafenib. Renal pelvis tumors. Retinoblastoma. |
|
v. 4. Rhabdomyosarcoma. Richter syndrome. Rituximab. Ruxolitinib. Salivary gland tumors. Sarcoma. Sargramostim. Saw palmetto. Scopolamine. Screening test. Second cancers. Secondhand smoke. Second-look surgery. Segmentectomy. Selinexor. Semustine. Sentinel lymph node biopsy. Sentinel lymph node mapping. Sexual issues for cancer patients. Sezary syndrome. Sigmoidoscopy. Simple mastectomy. Sipuleucel-T. Sirolimus. Skin biopsy. Skin cancer. Skin cancer, non-melanoma. Skin check. Small intestine cancer. Smoking cessation. Soft tissue sarcoma. Sorafenib. Spinal axis tumors. Spinal cord compression. Spiritual and ethical concerns. Splenectomy. Squamous cell carcinoma of the skin. Stem cell transplantation. Stenting. Stereotactic needle biopsy. Stereotactic surgery. Stomach cancer. Stomatitis. Streptozocin. Substance abuse. Sunitinib. Superior vena cava syndrome. Support groups. Supratentorial primitive neuroectodermal tumors. Suramin. Surgical oncology. Survivorship care plans. Syndrome of inappropriate antidiuretic hormone. Tacrolimus. Tamoxifen. Tanning. Taste alteration. Temozolomide. Temsirolimus. Teniposide. Testicular cancer. Testicular self-exam. Testolactone. Testosterone. Tetrahydrocannabinol. Thalidomide. Thioguanine. Thiotepa. Thoracentesis. Thoracic surgery. Thoracoscopy. Thoracotomy. Thrombocytopenia. Thrombopoietin. Thrush. Thymic cancer. Thymoma. Thyroid cancer. Thyroid nuclear medicine scan. Tisagenlecleucel. Topotecan. Toremifene. Tositumomab. Tracheostomy. Trametinib. Transfusion therapy. Transitional care. Transitional cell carcinoma. Transurethral bladder resection. Transvaginal ultrasound. Transverse myelitis. Trastuzumab. Tretinoin. Trichilemmal carcinoma. Trimetrexate. Triple negative breast cancer. Triptorelin pamoate. Tube enterostomy. Tumor grading. Tumor lysis syndrome. Tumor markers. Tumor necrosis factor. Tumor removal. Tumor staging. Ultrasonography. Upper gastrointestinal endoscopy. Upper gastrointestinal series. Ureterosigmoidostomy. Ureterostomy, cutaneous. Urethral cancer. Urostomy. Vaginal cancer. Valrubicin. Vaping. Vascular access. Venetoclax. Vinblastine. Vincristine. Vindesine. Vinorelbine. Vitamins. von Hippel-Lindau disease. von Recklinghausen neurofibromatosis. Vorinostat. Vulvar cancer. Waldenstrom macroglobulinemia. Warfarin. Weight loss. Whipple procedure. Whole brain radiotherapy. Wilms tumor. Xerostomia. X-rays. Zanubrutinib. Zoledronate. Zollinger-Ellison syndrome. Zolpidem. |
| Summary |
Comprehensive survey of cancers, cancer drugs, traditional and alternative treatments, side effects and diagnostic procedures. |
| Subject |
Cancer -- Encyclopedias.
|
|
Oncology.
|
| Added Author |
Gale (Firm)
|
| Note |
Encyclopedia of cancer |
| Other Form: |
Print version: Gale encyclopedia of cancer. Farmington Hills, Mich : Gale, [2020] 9780028677026 (DLC) 2020017980 |
| ISBN |
9780028677552 (electronic book) |
|
9780028677026 (set : hardcover) |
|
9780028677033 (volume 1 : hardcover) |
|
9780028677040 (volume 2 : hardcover) |
|
9780028677057 (volume 3 : hardcover) |
|
9780028683539 (volume 4 : hardcover) |
|
More Resources